Sensor-augmented pump therapy for pancreatogenic diabetes after total pancreatectomy : a prospective observational study

Sensor-augmented pump therapy for pancreatogenic diabetes after total pancreatectomy : a prospective observational study - Sensor-augmented pump therapy for pancreatogenic diabetes after total pancreatectomy : a prospective observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034234

Enrollment

Registered

2018-10-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatogenic diabetes

Interventions

Sensor-augmented insulin pump, 1 year.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. postoperative patient over 6 months after total pancreatectomy who isn't properly controlled in blood sugar 2. Performance Status 0, 1

Exclusion criteria

Exclusion criteria: 1. the patient who is difficult to do insulin self-injection 2. the patient who has another cancer 3. the patient who has active infection 4. pregnancy 5. the patient who received steroid medication

Design outcomes

Primary

Measure	Time frame
the percentage of time that glucose values are within the target range (70 to 180 mg/dL)	—

Countries

Japan

Contacts

Public ContactMasahiro Iseki

Tohoku University Graduate School of Medicine Department of Surgery

isekimasahiro@surg.med.tohoku.ac.jp0227177205

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026